FDA Approves Glucose Monitor That Can Be Worn for a Year [Yahoo! Finance]
Senseonics Holdings, Inc. (SENS)
Last senseonics holdings, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
senseonics.com/investor-relations
Company Research
Source: Yahoo! Finance
Senseonics, a medtech manufacturer developing long-term, implantable continuous glucose monitoring (CGM) systems, and Ascensia Diabetes Care today announced FDA approval for the Eversense 365 CGM system for people with Type 1 and Type 2 diabetes aged 18 years and older. The company said Eversense 365 is the world's first One Year CGM system. The extended life means fewer sensor changes, and only one insertion and one “Day 1” every year. Senseonics said other short-term CGM systems need to be changed every 10-14 days. The company also said that sensor survivability across 12 months reduces the burden of data interruptions from frequent short-term CGM sensor failures or change. Most Read Medical News: Eversense includes a small sensor that rests under the skin, meaning that it cannot be knocked off, and a silicone-based adhesive that can be changed daily. The removable transmitter which can be taken on and off without wasting a sensor or adding a warm up period and on-body vibrat
Show less
Read more
Impact Snapshot
Event Time:
SENS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SENS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SENS alerts
High impacting Senseonics Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
SENS
News
- Senseonics Stock Down Despite New FDA Approval for Eversense 365 [Yahoo! Finance]Yahoo! Finance
- Senseonics Holdings, Inc. (NYSE: SENS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Senseonics and Ascensia announce FDA approval for one-year CGM system [Yahoo! Finance]Yahoo! Finance
- Eversense 365 Receives FDA Clearance: The World’s First One Year CGMBusiness Wire
- Eversense 365 Receives FDA Clearance: The World’s First One Year CGMGlobeNewswire
SENS
Earnings
- 8/8/24 - In-Line
SENS
Analyst Actions
- 8/14/24 - HC Wainwright
SENS
Sec Filings
- 8/8/24 - Form 10-Q
- 8/8/24 - Form 8-K
- 7/3/24 - Form 4
- SENS's page on the SEC website